ArticleAtencion primaria2015

[Cost-effectiveness analysis of dapagliflozin compared to DPP4 inhibitors and other oral antidiabetic drugs in the treatment of type-2 diabetes mellitus in Spain].

Eduardo José Abad Paniagua et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.